Wegovy's price cut follows Mounjaro's success in India India key market for Novo Nordisk and Eli Lilly's obesity drugs Wegovy's semaglutide patent expires in India in March 2026 BENGALURU, Nov 11 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback